These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8024648)

  • 1. Pharmacokinetic compartmental model with n sites of absorption along the gastrointestinal tract.
    Plusquellec Y; Houin G
    Arzneimittelforschung; 1994 May; 44(5):679-82. PubMed ID: 8024648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers.
    Helmy SA
    Biopharm Drug Dispos; 2013 Jul; 34(5):288-301. PubMed ID: 23585286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorption.
    Plusquellec Y; Campistron G; Staveris S; Barre J; Jung L; Tillement JP; Houin G
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):225-39. PubMed ID: 3668801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption.
    Plusquellec Y; Efthymiopoulos C; Duthil P; Houin G
    Med Eng Phys; 1999 Oct; 21(8):525-32. PubMed ID: 10672785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline.
    Yu Z; Hwang SS; Gupta SK
    Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of veralipride after chronic administration in humans.
    Staveris S; Plusquellec Y; Campistron G; Barre J; Rochas MA; Jung L; Tillement JP; Koffell JC; Houin G
    J Pharm Sci; 1988 Jan; 77(1):64-7. PubMed ID: 3346823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a second site of absorption of veralipride in the human small intestine. Use of a new drug delivery telemetric shuttle.
    Staveris S; Houin G; Dufour A; Plusquellec Y; Grenier JF; Jung L; Koffel JC; Saivin S
    Arzneimittelforschung; 1994 Sep; 44(9):1068-72. PubMed ID: 7986246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans.
    Bressolle F; Brès J; Fauré-Jeantis A
    J Pharm Sci; 1992 Jan; 81(1):26-32. PubMed ID: 1619566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal absorption of sulpiride in rat.
    Mizuno N; Morita E; Nishikata M; Shinkuma D; Yamanaka Y
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):30-8. PubMed ID: 3800511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug forms for drug delivery into the gastrointestinal tract].
    Chalabala M; Rak J; Vitková M; Hederová S
    Ceska Slov Farm; 1995 Oct; 44(5):242-5. PubMed ID: 8520920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new physiologically based pharmacokinetic model for the prediction of gastrointestinal drug absorption: translocation model.
    Ando H; Hisaka A; Suzuki H
    Drug Metab Dispos; 2015 Apr; 43(4):590-602. PubMed ID: 25616403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variance of bioavailability of pharmaceutical preparations and analysis of factors affecting it].
    Mizuno N; Shinkuma D; Hamaguchi T
    Yakugaku Zasshi; 2003 Jul; 123(7):477-93. PubMed ID: 12875233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary dose-dependent pharmacokinetic study of veralipride.
    Staveris S; Houin G; Tillement JP; Jamet G; Schneider M; Jung L; Koffel JC
    J Pharm Sci; 1985 Jan; 74(1):94-6. PubMed ID: 3981429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of sulpiride after oral and intravenous administration in the rat and the dog.
    Segura J; Borja L; Bakke OM
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):88-95. PubMed ID: 999405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Theory and practice in design of gastrointestinal DDS].
    Nakano M
    Nihon Rinsho; 1989 Jun; 47(6):1249-54. PubMed ID: 2769986
    [No Abstract]   [Full Text] [Related]  

  • 17. A compartmental absorption and transit model for estimating oral drug absorption.
    Yu LX; Amidon GL
    Int J Pharm; 1999 Sep; 186(2):119-25. PubMed ID: 10486429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions.
    Thelen K; Coboeken K; Willmann S; Burghaus R; Dressman JB; Lippert J
    J Pharm Sci; 2011 Dec; 100(12):5324-45. PubMed ID: 21993815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of lefradafiban from different sites of the gastrointestinal tract.
    Drewe J; Narjes H; Heinzel G; Brickl RS; Rohr A; Beglinger C
    Br J Clin Pharmacol; 2000 Jul; 50(1):69-72. PubMed ID: 10886122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.